Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop-Reference-Cited by-同舟云学术

Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop

Published:2019-12 Issue:12 Volume:39 Page:2457-2467
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Rodriguez Annabelle¹,Trigatti Bernardo L.²,Mineo Chieko³,Knaack Darcy⁴,Wilkins John T.⁵,Sahoo Daisy⁴⁶,Asztalos Bela F.⁷,Mora Samia⁸,Cuchel Marina⁹,Pownall Henry J.¹⁰,Rosales Corina¹⁰,Bernatchez Pascal¹¹,Ribeiro Martins da Silva Amanda¹²,Getz Godfrey S.¹³,Barber Jacob L.¹⁴,Shearer Gregory C.¹⁵,Zivkovic Angela M.¹⁶,Tietge Uwe J.F.¹⁷¹⁸,Sacks Frank M.¹⁹,Connelly Margery A.²⁰,Oda Michael N.²¹,Davidson W. Sean²²,Sorci-Thomas Mary G.⁶,Vaisar Tomas²³,Ruotolo Giacomo²⁴,Vickers Kasey C.²⁵,Martel Catherine²⁶

Affiliation:

1. From the Center for Vascular Biology, Department of Cell Biology, University of Connecticut Health, Farmington (A.R.)

2. Department of Biochemistry and Biomedical Sciences, McMaster University, and Thrombosis and Atherosclerosis Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada (B.L.T.)

3. Center for Pulmonary and Vascular Biology, Department of Pediatrics and Cell Biology, University of Texas Southwestern Medical Center, Dallas (C.M.)

4. Department of Biochemistry (D.K., D.S.), Medical College of Wisconsin, Milwaukee

5. Division of Cardiology, Departments of Medicine and of Preventive Medicine, Northwestern University, Chicago, IL (J.T.W.)

6. Division of Endocrinology (D.S., M.G.S.-T.), Medical College of Wisconsin, Milwaukee

7. Human Nutrition Research Center, Tufts University, Boston, MA (B.F.A.)

8. Center for Lipid Metabolomics, Divisions of Preventive and Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (S.M.)

9. Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia (M.C.)

10. Institute for Academic Medicine, Houston Methodist, Weill Cornell Medical College, Houston, TX (H.J.P., C.R.)

11. Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Heart and Lung Innovation Centre, St Paul’s Hospital, Vancouver, BC, Canada (P.B.)

12. Institute of Chemistry, University of Sao Paulo, Brazil (A.R.M.d.S.)

13. Department of Pathology, University of Chicago, IL (G.S.G.)

14. Department of Exercise Science, University of South Carolina, Columbia (J.L.B.)

15. Department Nutritional Sciences, The Pennsylvania State University, University Park (G.C.S.)

16. Department of Nutrition, University California Davis (A.M.Z.)

17. Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden (U.J.F.T.)

18. Clinical Chemistry, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden (U.J.F.T.)

19. Harvard T.H. Chan School of Public Health, Boston, MA (F.M.S.)

20. Laboratory Corporation of America Holdings (LabCorp), Morrisville, NC (M.A.C.)

21. DRx BioLogics, Inc, Fairfield, CA (M.N.O.)

22. Department of Pathology and Laboratory Medicine, University of Cincinnati, OH (W.S.D.)

23. UW Medicine Diabetes Institute, University of Washington, Seattle (T.V.)

24. Eli Lilly and Company, Indianapolis, IN (G.R.)

25. Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (K.C.V.)

26. Montreal Heart Institute, Montreal and Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada (C.M.).

Abstract

The HDL (high-density lipoprotein) Workshop was established in 2009 as a forum for candid discussions among academic basic scientists, clinical investigators, and industry researchers about the role of HDL in cardiovascular disease. This ninth HDL Workshop was held on May 16 to 17, 2019 in Boston, MA, and included outstanding oral presentations from established and emerging investigators. The Workshop featured 5 sessions with topics that tackled the role of HDL in the vasculature, its structural complexity, its role in health and disease states, and its interaction with the intestinal microbiome. The highlight of the program was awarding the Jack Oram Award to the distinguished professor emeritus G.S. Getz from the University of Chicago. The tenth HDL Workshop will be held on May 2020 in Chicago and will continue the focus on intellectually stimulating presentations by established and emerging investigators on novel roles of HDL in cardiovascular and noncardiovascular health and disease states.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference57 articles.

1. HW HDL Workshop. https://hdlworkshop.org/. Accessed August 8 2019.

2. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

3. American Heart Association. 2018 Prevention Guidelines Tool CV Risk Calculator. http://static.heart.org/riskcalc/app/index.html#!/baseline-risk. Accessed July 8 2019.

4. Framingham Heart Study. Hard Coronary Heart Disease (10-year risk). https://www.framinghamheartstudy.org/fhs-risk-functions/hard-coronary-heart-disease-10-year-risk/. Accessed July 8 2019.

5. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDL functionality is dependent on hepatocyte stress defense factors Nrf1 and Nrf2;Frontiers in Physiology;2023-07-12

2. Reconfigurable Peptide Analogs of Apolipoprotein A-I Reveal Tunable Features of Nanodisc Assembly;Langmuir;2023-01-10

3. Association of High-Density Lipoprotein Subclasses Levels with Sleep Duration and Other Lifestyles in Middle-Aged and Elderly Women: Cross-Sectional Study;Metabolic Syndrome and Related Disorders;2022-11-01

4. A Nutrigenetic Update on CETP Gene–Diet Interactions on Lipid-Related Outcomes;Current Atherosclerosis Reports;2022-01-31

5. Artificial high‐density lipoprotein‐mimicking nanotherapeutics for the treatment of cardiovascular diseases;WIREs Nanomedicine and Nanobiotechnology;2021-07-14